Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Brossart

Showing results (41-50 of 266) with videos related to

Pageof 27
Sort By:
Experimental Dermatology|November 29, 2016
JAK inhibitor ruxolitinib inhibits the expression of cytokines characteristic of cutaneous lupus erythematosusAnna Sophie Klaeschen, Dominik Wolf, Peter Brossart, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2020
Immune Checkpoint Imaging in Oncology: A Game Changer Toward Personalized Immunotherapy?Susanne Lütje, Georg Feldmann, Markus Essler, et al.
Cancer Immunology, Immunotherapy : CII|June 26, 2021
The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cellsChristiane Braun, Sebastian Schlaweck, Solveig Nora Daecke, et al.
Frontiers in Medicine|April 10, 2023
Development and implementation of a comprehensive ultrasound curriculum for medical students: The Bonn internship point-of-care-ultrasound curriculum (BI-POCUS)Florian Recker, Valentin Sebastian Schäfer, Wolfgang Holzgreve, et al.
Nature Reviews. Clinical Oncology|June 24, 2020
Towards new horizons: characterization, classification and implications of the tumour antigenic repertoireSebastian P Haen, Markus W Löffler, Hans-Georg Rammensee, et al.
BMC Biology|March 12, 2021
BG-flow, a new flow cytometry tool for G-quadruplex quantification in fixed cellsAlessio De Magis, Melanie Kastl, Peter Brossart, et al.
Annals of the New York Academy of Sciences|June 17, 2005
Effect of tyrosine kinase inhibition using imatinib on normal lymphohematopoietic cellsStefan Balabanov, Silke Appel, Lothar Kanz, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 26, 2022
Comparison of Empiric Antibiotic Escalation Therapy with Vancomycin (VAN) versus Linezolid (LIN) in Patients with Febrile NeutropeniaKarin Mayer, Nicolaus Hegge, Ernst Molitor, et al.
Case Reports in Hematology|September 4, 2024
Acute Coronary Syndrome as an Unusual Initial Presentation of T-Prolymphocytic Leukemia: A Case Report and Review of the LiteratureChristian R Klein, Felix Jansen, Peter Brossart, et al.
Deutsche Medizinische Wochenschrift (1946)|August 8, 2018
[Survey of physicians on dealing with the topic "Tobacco consumption in patients with lung cancer"]Markus Bleckwenn, Asya Kaluç, Mathias Zipfel, et al.
Pageof 27

Showing results (41-50 of 266) with videos related to

Sort By:
Pageof 27
Experimental Dermatology|November 29, 2016
JAK inhibitor ruxolitinib inhibits the expression of cytokines characteristic of cutaneous lupus erythematosusAnna Sophie Klaeschen, Dominik Wolf, Peter Brossart, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2020
Immune Checkpoint Imaging in Oncology: A Game Changer Toward Personalized Immunotherapy?Susanne Lütje, Georg Feldmann, Markus Essler, et al.
Cancer Immunology, Immunotherapy : CII|June 26, 2021
The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cellsChristiane Braun, Sebastian Schlaweck, Solveig Nora Daecke, et al.
Frontiers in Medicine|April 10, 2023
Development and implementation of a comprehensive ultrasound curriculum for medical students: The Bonn internship point-of-care-ultrasound curriculum (BI-POCUS)Florian Recker, Valentin Sebastian Schäfer, Wolfgang Holzgreve, et al.
Nature Reviews. Clinical Oncology|June 24, 2020
Towards new horizons: characterization, classification and implications of the tumour antigenic repertoireSebastian P Haen, Markus W Löffler, Hans-Georg Rammensee, et al.
BMC Biology|March 12, 2021
BG-flow, a new flow cytometry tool for G-quadruplex quantification in fixed cellsAlessio De Magis, Melanie Kastl, Peter Brossart, et al.
Annals of the New York Academy of Sciences|June 17, 2005
Effect of tyrosine kinase inhibition using imatinib on normal lymphohematopoietic cellsStefan Balabanov, Silke Appel, Lothar Kanz, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 26, 2022
Comparison of Empiric Antibiotic Escalation Therapy with Vancomycin (VAN) versus Linezolid (LIN) in Patients with Febrile NeutropeniaKarin Mayer, Nicolaus Hegge, Ernst Molitor, et al.
Case Reports in Hematology|September 4, 2024
Acute Coronary Syndrome as an Unusual Initial Presentation of T-Prolymphocytic Leukemia: A Case Report and Review of the LiteratureChristian R Klein, Felix Jansen, Peter Brossart, et al.
Deutsche Medizinische Wochenschrift (1946)|August 8, 2018
[Survey of physicians on dealing with the topic "Tobacco consumption in patients with lung cancer"]Markus Bleckwenn, Asya Kaluç, Mathias Zipfel, et al.
Pageof 27